← Back
$DNLI All transactions

Denali Therapeutics Inc.

▼ SELL 10b5-1 Plan

$ Value

$40K

Shares

2,937

Price

$14

Filed

Aug 14

Insider

Name

Ho Carole

Title

Chief Medical Officer

CIK

0001724605

Roles

Officer

Transaction Details

Transaction Date

2025-08-12

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

217,391

Footnotes

Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units. | The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $13.34 to $13.58 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. | Includes 128,405 Unvested RSUs. | The sales reported by the Reporting Person were affected pursuant to a Rule 10b5-1 trading plan adopted December 11, 2024. | The shares are held of record by the Rohatgi-Ho Family 2009 Revocable Trust, for which Reporting Person serves as trustee. | The shares are held of record by The Rohatgi-Ho Irrevocable GST Trust for the benefit of the Reporting Person's children.

Filing Info

Accession No.

0001714899-25-000176

Form Type

4

Issuer CIK

0001714899

Ho Carole's History

Date Ticker Type Value
2025-08-13 DNLI $12K
2025-08-12 DNLI $40K
2025-08-05 DNLI M $30K
2025-08-05 DNLI M $0
2025-07-31 RPRX A $0
2025-07-31 RPRX A $0
2025-06-04 BEAM A $0

Other Insiders at DNLI (90d)

No other insider activity at this issuer in the last 90 days.